Treatment Discontinuation and Clinical Events in Type 2 Diabetes Patients Treated with Dipeptidyl Peptidase-4 Inhibitors or NPH Insulin as Third-Line Therapy

OBJECTIVE: To compare dipeptidyl peptidase-4 (DPP-4) inhibitors with neutral protamine Hagedorn (NPH) insulin, in terms of effectiveness and safety for the management of patients with type 2 diabetes mellitus (DM2) not controlled on metformin and sulfonylureas. METHODS: A retrospective cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales: Moura, Cristiano S., Rosenberg, Zale B., Abrahamowicz, Michal, Bernatsky, Sasha, Behlouli, Hassan, Pilote, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866860/
https://www.ncbi.nlm.nih.gov/pubmed/29713649
http://dx.doi.org/10.1155/2018/4817178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866860/
https://www.ncbi.nlm.nih.gov/pubmed/29713649
http://dx.doi.org/10.1155/2018/4817178

Ejemplares similares